ZA983806B - Fixed-dose association of an angiotensin-converting enzyme inhibitor and of a calcium channel antagonist method for preparation and use thereof in the treatment of cardiovascular illnesses - Google Patents

Fixed-dose association of an angiotensin-converting enzyme inhibitor and of a calcium channel antagonist method for preparation and use thereof in the treatment of cardiovascular illnesses

Info

Publication number
ZA983806B
ZA983806B ZA983806A ZA983806A ZA983806B ZA 983806 B ZA983806 B ZA 983806B ZA 983806 A ZA983806 A ZA 983806A ZA 983806 A ZA983806 A ZA 983806A ZA 983806 B ZA983806 B ZA 983806B
Authority
ZA
South Africa
Prior art keywords
angiotensin
preparation
treatment
fixed
calcium channel
Prior art date
Application number
ZA983806A
Other languages
English (en)
Inventor
Pedro Canovas Soler
Joaquin Delgadillo Duarte
Luis Manuel Micheto Escuder
Original Assignee
Vita Invest Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8299270&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA983806(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vita Invest Sa filed Critical Vita Invest Sa
Publication of ZA983806B publication Critical patent/ZA983806B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
ZA983806A 1997-05-13 1998-05-06 Fixed-dose association of an angiotensin-converting enzyme inhibitor and of a calcium channel antagonist method for preparation and use thereof in the treatment of cardiovascular illnesses ZA983806B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009701017A ES2125198B1 (es) 1997-05-13 1997-05-13 Asociacion a dosis fija de un inhibidor de la enzima convertidora de angiotensina y de un antagonista de los canales de calcio, procedimiento para su preparacion y su utilizacion para el tratamiento de enfermees cardiovasculares.

Publications (1)

Publication Number Publication Date
ZA983806B true ZA983806B (en) 1999-02-19

Family

ID=8299270

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA983806A ZA983806B (en) 1997-05-13 1998-05-06 Fixed-dose association of an angiotensin-converting enzyme inhibitor and of a calcium channel antagonist method for preparation and use thereof in the treatment of cardiovascular illnesses

Country Status (23)

Country Link
EP (1) EP0884054B9 (cs)
JP (1) JP3576806B2 (cs)
CN (1) CN1146418C (cs)
AR (1) AR011730A1 (cs)
AT (1) ATE236653T1 (cs)
AU (1) AU735404B2 (cs)
BR (1) BR9805597A (cs)
CA (1) CA2234899C (cs)
CZ (1) CZ292616B6 (cs)
DE (1) DE69813083T2 (cs)
DK (1) DK0884054T3 (cs)
ES (2) ES2125198B1 (cs)
HU (1) HUP9801075A3 (cs)
IL (1) IL124253A (cs)
NO (1) NO315545B1 (cs)
NZ (1) NZ330447A (cs)
PL (1) PL192117B1 (cs)
PT (1) PT884054E (cs)
RU (1) RU2182002C2 (cs)
SK (1) SK284337B6 (cs)
TR (1) TR199800847A3 (cs)
TW (1) TW562679B (cs)
ZA (1) ZA983806B (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU226950B1 (en) * 1999-11-03 2010-03-29 Richter Gedeon Nyrt The magnesium salt of enalapril and antihypertensive pharmaceutical composition containing it
TWI246921B (en) * 2000-04-11 2006-01-11 Sankyo Co Stabilized pharmaceutical composition with calcium blocker
HU230253B1 (hu) * 2001-01-26 2015-11-30 Merck Sharp & Dohme Corp Peroxiszóma proliferátor-aktivált receptor (PPAR) aktivátor(ok) és szterin-abszorpció inhibitor(ok) kombinációi és alkalmazásuk vaszkuláris indikációk kezelésére
JP4633469B2 (ja) * 2002-12-16 2011-02-16 キッセイ薬品工業株式会社 経口固形医薬
RU2618471C2 (ru) * 2012-12-03 2017-05-03 Закрытое Акционерное Общество "Вертекс" Пероральная фармацевтическая композиция диуретика и ингибитора АПФ в микронизированной форме, лекарственное средство и его применение
CN109350733A (zh) * 2018-06-08 2019-02-19 山东理工职业学院 一种马来酸依那普利片剂的制备方法
CN109985013B (zh) * 2019-05-10 2021-08-10 河北君圣药业有限公司 一种尼群地平分散片及其制备方法
CN115501224A (zh) * 2022-10-09 2022-12-23 南昌大学第一附属医院 马来酸依那普利叶酸片联合通心络在制备治疗高血压合并颈动脉硬化药物的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3437917A1 (de) * 1984-10-17 1986-04-17 Bayer Ag, 5090 Leverkusen Kombination von dihydropyridinen mit ace-hemmern sowie ihre verwendung in arzneimitteln
USH734H (en) * 1988-03-07 1990-02-06 E. R. Squibb & Sons, Inc. Method for inhibiting onset of or treating migraine headaches employing an ACE inhibitor
JPH01275529A (ja) * 1988-03-21 1989-11-06 E R Squibb & Sons Inc 晩発性運動障害の抑制治療剤
CA2007525A1 (en) * 1989-01-30 1990-07-30 Zola P. Horovitz Method for facilating dieting employing an ace inhibitor
US5160744A (en) * 1991-06-27 1992-11-03 Alza Corporation Verapmil therapy
US5246944A (en) * 1991-08-13 1993-09-21 Merck & Co., Inc. Quinoline angiotensin ii antagonists incorporating a substituted benzyl element
SI9111842A (sl) * 1991-11-25 1998-04-30 Krka Stabilna formulacija soli enalaprila, postopek za njeno pripravo in njena uporaba
SI9300504A (en) * 1993-09-28 1995-04-30 Krka Process for preparation solid dispersions and deposits of calcium antagonist dihidropyrimidine derivates and pharmaceutical compositions comprising the same
US5573780A (en) * 1995-08-04 1996-11-12 Apotex Usa Inc. Stable solid formulation of enalapril salt and process for preparation thereof

Also Published As

Publication number Publication date
PL326246A1 (en) 1998-11-23
CA2234899C (en) 2004-08-10
SK61698A3 (en) 1998-12-02
EP0884054B9 (en) 2007-02-14
JPH11124330A (ja) 1999-05-11
CN1212869A (zh) 1999-04-07
ES2197443T3 (es) 2004-01-01
BR9805597A (pt) 2000-04-11
AR011730A1 (es) 2000-08-30
JP3576806B2 (ja) 2004-10-13
ES2125198A1 (es) 1999-02-16
NO315545B1 (no) 2003-09-22
ES2125198B1 (es) 1999-11-16
HU9801075D0 (en) 1998-07-28
CA2234899A1 (en) 1998-11-13
EP0884054A2 (en) 1998-12-16
NO982112D0 (no) 1998-05-08
CZ138198A3 (cs) 1998-12-16
TR199800847A2 (xx) 1999-10-21
ATE236653T1 (de) 2003-04-15
HUP9801075A2 (hu) 1999-01-28
DE69813083T2 (de) 2004-05-27
PL192117B1 (pl) 2006-09-29
CN1146418C (zh) 2004-04-21
IL124253A (en) 2003-01-12
HUP9801075A3 (en) 2000-12-28
SK284337B6 (sk) 2005-02-04
NO982112L (no) 1998-11-16
EP0884054A3 (en) 2000-08-23
DE69813083D1 (de) 2003-05-15
AU6597398A (en) 1998-11-19
NZ330447A (en) 1998-12-23
TR199800847A3 (tr) 1999-10-21
TW562679B (en) 2003-11-21
PT884054E (pt) 2003-08-29
AU735404B2 (en) 2001-07-05
EP0884054B1 (en) 2003-04-09
CZ292616B6 (cs) 2003-11-12
DK0884054T3 (da) 2003-07-21
RU2182002C2 (ru) 2002-05-10

Similar Documents

Publication Publication Date Title
IL122813A0 (en) Thrombin inhibitors their preparation and use
HUP0101809A3 (en) Inhibitors of type 5 and type 3 17betha-hydroxysteroid dehydrogenase and methods for their use
HUP9902034A3 (en) Succinimide and maleimide cytokine inhibitors
HUP0104500A3 (en) Thrombin inhibitor dipeptide derivatives and their use
HU9700602D0 (en) New inhibitors of bone-resorption and vitronectine-receptor-antagonists
PL331254A1 (en) Phosphonianic inhibitors of matrix metaloproteases
PL333505A1 (en) Benzamido-aldehydes and their application as inhibitors of cysteinic proteases
IL122186A (en) Heterocycles as inhibitors of leucotype adhesion and as vla-4-antagonists
AU7709798A (en) Textured ligating band and method of use of same
EP0686642A3 (en) Modified guanidino and amidino thrombin inhibitors
PL333434A1 (en) Aminoguanidines and alkoxyguanidines as inhibitors of proteases
IL127885A0 (en) Amidino derivatives and their use as thrombin inhibitors
PL334846A1 (en) Sulphamidic inhibitors of metaloproteases
ZA988017B (en) Parp inhibitors pharmaceutical compositions comprising same and methods of using same
IL133490A0 (en) New amidino derivatives and their use as thrombin inhibitors
HUP9801989A3 (en) Medicament with angiotensin converting enzyme (ace) inhibitors suitable for transdermal application
AU3005997A (en) Inhibitors of picornavirus 3c proteases and methods for their use and preparation
HU0900792D0 (en) Use of renin-angiotensin inhibitors
HUP9801227A3 (en) Pharmaceutical compositions comprising monoamine oxidase b inhibitors and their use
ZA983806B (en) Fixed-dose association of an angiotensin-converting enzyme inhibitor and of a calcium channel antagonist method for preparation and use thereof in the treatment of cardiovascular illnesses
ZA9710989B (en) Polyprolyl inhibitors of cyclophilin
AU1456899A (en) Human protein kinase and kinase inhibitors
GB9524267D0 (en) Enzyme inhibitor and method
GB2336190B (en) Timber joint and method of manufacture
AU6819798A (en) Oligopeptidic inhibitors of elastases and methods of preparation thereof